The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2
by Council on Pharmacy and Chemistry
Listen FreeFree AI audiobook with natural voice. No signup required.
Chapters (1168)
- THE PROPAGANDA FOR REFORM IN Proprietary Medicines
- PREFACE TO VOLUME 2
- PREFACE TO VOLUME 1: NINTH EDITION
- RESOLUTION ENDORSING THE WORK OF THE COUNCIL ON PHARMACY AND CHEMISTRY
- Presented at the San Francisco Session and Signed by All the Members of the House of Delegates in Attendance
- TABLE OF CONTENTS
- PART I REPORTS OF THE COUNCIL ON PHARMACY AND CHEMISTRY
- FOREWORD
- THE COUNCIL ON PHARMACY AND CHEMISTRY
- OFFICIAL RULES OF THE COUNCIL ON PHARMACY AND CHEMISTRY
- Introduction
- Rules Governing the Admission of Proprietary Articles to the Book New and Nonofficial Remedies
- Explanatory Comments on the Rules
- Explanation of Rule 1: Composition
- Explanation of Rule 2: Identification
- Explanation of Rule 3: Direct Advertising
- Explanation of Rule 4: Indirect Advertising
- Explanation of Rule 5: False Claims as to Origin
- Explanation of Rule 6: Unwarranted Therapeutic Claims
- Explanation of Rule 7: Poisonous Substances
- Explanation of Rule 8: Objectionable Names
- Explanation of Rule 10: Unscientific and Useless Articles
- THE COUNCIL ON PHARMACY AND CHEMISTRY, PRESENT AND FUTURE [A]
- “ACCEPTED BY THE COUNCIL ON PHARMACY AND CHEMISTRY”
- HELPING THE COUNCIL
- DELAYS IN PASSING ON PRODUCTS
- Report of the Council on Pharmacy and Chemistry
- COOPERATION OF THE PHARMACEUTICAL HOUSES
- Report of the Council on Pharmacy and Chemistry
- BUDWELL’S EMULSION OF COD-LIVER OIL, NOS. 1 AND 2
- Report of the Council on Pharmacy and Chemistry
- RHEUMALGINE
- Report of the Council on Pharmacy and Chemistry
- GRAY’S GLYCERINE TONIC
- Report of the Council on Pharmacy and Chemistry
- TONGALINE AND PONCA COMPOUND
- Report of the Council on Pharmacy and Chemistry
- ALFATONE
- Report of the Council on Pharmacy and Chemistry
- ARTICLES REFUSED RECOGNITION
- Report of the Council on Pharmacy and Chemistry
- Uricsol
- Jubol
- Urodonal
- FORMAMINT
- Report of the Council on Pharmacy and Chemistry
- Experimental Data
- Discussion
- HYDRAGOGIN
- Report of the Council on Pharmacy and Chemistry
- FILUDINE
- Report of the Council on Pharmacy and Chemistry
- LACTOPEPTINE AND ELIXIR LACTOPEPTINE
- Report of the Council on Pharmacy and Chemistry
- Manufacturers’ Protest and Council’s Answer
- Report of Referee A
- Report of Referee B
- IODUM-MILLER AND IOD-IZD-OIL (MILLER’S)
- Report of the Council on Pharmacy and Chemistry
- ELIXIR IODO-BROMIDE OF CALCIUM COMP. “WITHOUT MERCURY” AND “WITH MERCURY”
- Report of the Council on Pharmacy and Chemistry
- LECITHIN PREPARATIONS OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- Lecithin Preparations
- PROPRIETARY NAMES FOR LIQUID PETROLATUM
- Report of the Council on Pharmacy and Chemistry
- SENG
- Report of the Council on Pharmacy and Chemistry
- FROSST’S BLAUD CAPSULES
- Report of the Council on Pharmacy and Chemistry
- TYREE’S ELIXIR OF BUCHU AND HYOSCYAMUS COMPOUND
- Report of the Council on Pharmacy and Chemistry
- HYDROLEINE
- Report of the Council on Pharmacy and Chemistry
- CURATIVE VACCINE, BRUSCHETTINI
- Report of the Council on Pharmacy and Chemistry
- STEARNS’ WINE
- Report of the Council on Pharmacy and Chemistry
- PROTONUCLEIN AND PROTONUCLEIN BETA
- Report of the Council on Pharmacy and Chemistry
- HYDROPSIN
- Report of the Council on Pharmacy and Chemistry
- DIGITALYSATUM
- Report of the Council on Pharmacy and Chemistry
- SO-CALLED SECRETIN PREPARATIONS
- Report of the Council on Pharmacy and Chemistry
- HAS SECRETIN A THERAPEUTIC VALUE? [B][C]
- ARTICLES REFUSED RECOGNITION
- Report of the Council on Pharmacy and Chemistry
- Radio-Rem
- Olio-Phlogosis
- THE HYPOPHOSPHITE FALLACY
- Report of the Council on Pharmacy and Chemistry
- PULVOIDS CALCYLATES
- Report of the Council on Pharmacy and Chemistry
- SULFURYL MONAL
- Report of the Council on Pharmacy and Chemistry
- MARK WHITE GOITER SERUM AND MARK WHITE IODINIZED OIL
- Report of the Council on Pharmacy and Chemistry
- Editorial Note on the Mark White “Serum”
- KORA-KONIA
- Report of the Council on Pharmacy and Chemistry
- THE THERAPEUTIC VALUE OF THE GLYCEROPHOSPHATES
- Report of the Council on Pharmacy and Chemistry
- HYDRAS
- Report of the Council on Pharmacy and Chemistry
- BROMIN-IODIN COMPOUND
- Report of the Council on Pharmacy and Chemistry
- AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- ALPHOZONE OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- CALCIUM GLYCEROPHOSPHATE AND SODIUM GLYCEROPHOSPHATE OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- GARDNER’S SYRUP OF AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- GLUTEN PRODUCTS MADE BY THE KELLOGG FOOD COMPANY
- Report of the Council on Pharmacy and Chemistry
- Referee’s Report
- IODO-MANGAN OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- LIQUID ALBOLENE
- Report of the Council on Pharmacy and Chemistry
- NAPHEY’S MEDICATED UTERINE WAFERS
- Report of the Council on Pharmacy and Chemistry
- NUJOL
- Report of the Council on Pharmacy and Chemistry
- PULVOIDS NATRIUM COMPOUND
- Report of the Council on Pharmacy and Chemistry
- SALOFORM
- Report of the Council on Pharmacy and Chemistry
- SECRETOGEN
- Report of the Council on Pharmacy and Chemistry
- IRON CITRATE GREEN
- Report of the Council on Pharmacy and Chemistry
- ASPIRIN
- Report of the Council on Pharmacy and Chemistry
- PIL. CASCARA COMPOUND-ROBINS
- Report of the Council on Pharmacy and Chemistry
- CASTA-FLORA
- Report of the Council on Pharmacy and Chemistry
- FIRWEIN
- Report of the Council on Pharmacy and Chemistry
- FIROLYPTOL PLAIN AND FIROLYPTOL WITH KREOSOTE
- Report of the Council on Pharmacy and Chemistry
- BINIODOL
- Report of the Council on Pharmacy and Chemistry
- COMPARATIVE SYMPTOMS RESULTING FROM THE USE OF SEVERAL OILY SUSPENSIONS OF RED MERCURIC IODID (MERCURY BINIODID)
- Report of Dr. H. N. Cole[D]
- Report of Dr. Albert Keidel
- CORPORA LUTEA (SOLUBLE EXTRACT), PARKE, DAVIS & CO.
- Report of the Council on Pharmacy and Chemistry
- WHEELER’S TISSUE PHOSPHATES
- Report of the Council on Pharmacy and Chemistry
- WHEELER’S TISSUE PHOSPHATES
- THE CLAIMED GALACTAGOGUE EFFECTS OF NUTROLACTIS AND GOAT’S RUE NOT SUBSTANTIATED
- Report of the Council on Pharmacy and Chemistry
- THE ALLEGED GALACTAGOGUE ACTION OF GALEGA AND NUTROLACTIS [E][F]
- THE RUSSELL EMULSION AND THE RUSSELL PREPARED GREEN BONE
- Report of the Council on Pharmacy and Chemistry
- BROM-I-PHOS
- Report of the Council on Pharmacy and Chemistry
- CREOSOTE-DELSON AND CREOFOS
- Report of the Council on Pharmacy and Chemistry
- TRINER’S AMERICAN ELIXIR OF BITTER WINE
- Report of the Council on Pharmacy and Chemistry
- TRIMETHOL
- Report of the Council on Pharmacy and Chemistry
- FERRIVINE, INTRAMINE AND COLLOSOL IODINE
- Report of the Council on Pharmacy and Chemistry
- ESKAY’S NEURO PHOSPHATES
- Report of the Council on Pharmacy and Chemistry
- K-Y LUBRICATING JELLY
- Report of the Council on Pharmacy and Chemistry
- ZIRATOL
- Report of the Council on Pharmacy and Chemistry
- GONOSAN
- Report of the Council on Pharmacy and Chemistry
- Appendix
- ALCRESTA IPECAC
- Report of the Council on Pharmacy and Chemistry
- IODEOL AND IODAGOL
- Report of the Council on Pharmacy and Chemistry
- Summary of Referee’s Report
- CAPSULES BISMUTH RESORCINOL COMPOUND NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- DIXON’S TUBERCLE BACILLI EXTRACT AND DIXON’S SUSPENSION OF DEAD TUBERCLE BACILLI
- Report of the Council on Pharmacy and Chemistry
- FORMOSOL
- Report of the Council on Pharmacy and Chemistry
- IODOLENE, A SOLUTION OF IODIN IN LIQUID PETROLATUM, INADMISSIBLE TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- KALAK WATER
- Report of the Council on Pharmacy and Chemistry
- MINSON’S SOLUBLE IODIN “KELPIDINE” NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- NUTONE
- Report of the Council on Pharmacy and Chemistry
- TRI-ARSENOLE, L. O. COMPOUND NO. 1 AND L. O. COMPOUND NO. 2
- Report of the Council on Pharmacy and Chemistry
- UNCTOL
- Report of the Council on Pharmacy and Chemistry
- V-E-M (SCHOONMAKER LABORATORIES, INC.)
- Report of the Council on Pharmacy and Chemistry
- HEMO-THERAPIN
- Report of the Council on Pharmacy and Chemistry
- VENOSAL
- Report of the Council on Pharmacy and Chemistry
- SECRETIN-BEVERIDGE AND THE U. S. PATENT LAW
- Report of the Council on Pharmacy and Chemistry
- THE QUESTION OF THE STABILITY OF SECRETIN
- NEED FOR PATENT LAW REVISION
- Report of the Committee on Patent-Law Revision of the Council on Pharmacy and Chemistry of the American Medical Association
- SURGODINE
- Report of the Council on Pharmacy and Chemistry
- MEDEOL SUPPOSITORIES
- Report of the Council on Pharmacy and Chemistry
- GUAIODINE
- Report of the Council on Pharmacy and Chemistry
- SEVERAL “MIXED” VACCINES NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- Mixed Vaccines-Abbott
- Catarrhal Vaccine Combined-Lilly and Influenza Mixed Vaccine-Lilly
- Influenza Serobacterin Mixed-Mulford
- Sherman’s Mixed Vaccine No. 40
- OPHTHALMOL-LINDEMANN
- Report of the Council on Pharmacy and Chemistry
- SILVOL INELIGIBLE FOR N. N. R.
- Report of the Council on Pharmacy and Chemistry
- KATHARMON
- Report of the Council on Pharmacy and Chemistry
- IODINIZED EMULSION (SCOTT) AND CREOSOTONIC (SCOTT)
- Report of the Council on Pharmacy and Chemistry
- Iodinized Emulsion (Scott)
- Creosotonic (Scott)
- CAMPETRODIN AND CAMPETRODIN NO. 2
- Report of the Council on Pharmacy and Chemistry
- CARMINZYM
- Report of the Council on Pharmacy and Chemistry
- PHILLIPS’ PHOSPHO-MURIATE OF QUININE COMP.
- Report of the Council on Pharmacy and Chemistry
- B. IODINE AND B. OLEUM IODINE
- Report of the Council on Pharmacy and Chemistry
- B. IODINE PRODUCTS
- ANTITHYROID PREPARATIONS (ANTITHYROIDIN-MOEBIUS AND THYREOIDECTIN) OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- CEPHAELIN AND SYRUP CEPHAELIN-LILLY OMITTED FROM N. N. R. AND SYRUP EMETIC-LILLY NOT ACCEPTED
- Report of Council on Pharmacy and Chemistry
- COLALIN OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- FORAL
- Report of the Council on Pharmacy and Chemistry
- GRANULAR EFFERVESCENT BROMIDE AND ACETANILID COMPOUND-MULFORD
- Report of the Council on Pharmacy and Chemistry
- HOLADIN AND BILE SALT MIXTURES
- Report of the Council on Pharmacy and Chemistry
- LIQUOR SANTAIVA, S. & D., OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- MALTZYME, MALTZYME WITH CASCARA SAGRADA, MALTZYME WITH COD LIVER OIL, MALTZYME FERRATED AND MALTZYME WITH YERBA SANTA OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- METHAFORM OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- PINEAL GLAND, RED BONE-MARROW AND THYMUS GLAND AND THEIR PREPARATIONS OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- Pineal Gland
- Red Bone-Marrow
- Thymus Gland
- PIPERAZINE AND LYCETOL OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- STANOLIND LIQUID PARAFFIN OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- WESTERFIELD’S DIGITALIS TABLETS
- Report of the Council on Pharmacy and Chemistry
- XEROFORM-HEYDEN AND BISMUTH TRIBROMPHENATE-MERCK OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- CREAM OF MUSTARD REFUSED RECOGNITION
- Report of the Council on Pharmacy and Chemistry
- “PLURIGLANDULAR” MIXTURES
- Report of the Council on Pharmacy and Chemistry
- CERELENE NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- COLLOSOL COCAINE NOT ADMITTED TO N. N. R
- Report of the Council on Pharmacy and Chemistry
- CUPRASE NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- COLLOSOL PREPARATIONS
- Report of the Council on Pharmacy and Chemistry
- Additional Notes on Collosol Evidence
- PULVOIDS CALCYLATES COMPOUND
- Report of the Council on Pharmacy and Chemistry
- PROTEOGENS OF THE WM. S. MERRELL COMPANY
- Report of the Council on Pharmacy and Chemistry
- Report of First Referee on Proteogens
- Report of Second Referee Reviewing Manufacturers’ Reply
- “ARSENOVEN S. S.” AND “ARSENO-METH-HYD”
- Report of the Council on Pharmacy and Chemistry
- HORMOTONE AND HORMOTONE WITHOUT POST-PITUITARY
- Report of the Council on Pharmacy and Chemistry.
- FORMALDEHYDE LOZENGES
- Report of the Council on Pharmacy and Chemistry
- Hex-Iodin
- Formitol Tablets
- Cin-U-Form Lozenges
- LAVORIS
- Report of the Council on Pharmacy and Chemistry
- MEDINAL
- Report of the Council on Pharmacy and Chemistry
- OMISSION OF COTARNIN SALTS (STYPTICIN AND STYPTOL) FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- MICAJAH’S WAFERS AND MICAJAH’S SUPPOSITORIES
- Report of the Council on Pharmacy and Chemistry
- ALKALITHIA
- Report of the Council on Pharmacy and Chemistry
- ARHOVIN OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- CHLORON, CHLORAX AND NUMBER “3”
- Report of the Council on Pharmacy and Chemistry
- Chloron
- Chlorax
- Number “3”
- ELARSON OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- IODIPHOS
- Report of the Council on Pharmacy and Chemistry
- MERVENOL AND ARMERVENOL NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- NORMAL PHENOL SERUM (CANO) AND METHYL-PHENOL SERUM (CANO) NOT ACCEPTED FOR N. N. R.
- Report of the Council on Pharmacy and Chemistry
- SOAMIN OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- SOME MIXED VACCINES NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- SOMNOFORM
- Report of the Council on Pharmacy and Chemistry
- TABLETS FORMOTHALATES
- Report of the Council on Pharmacy and Chemistry
- TRIPLE ARSENATES WITH NUCLEIN
- Report of the Council on Pharmacy and Chemistry
- “ANTI-PNEUMOCOCCIC OIL” AND THE USE OF CAMPHOR IN PNEUMONIA
- Report of the Council on Pharmacy and Chemistry
- DIAL “CIBA”
- Report of the Council on Pharmacy and Chemistry
- APOTHESINE
- Report of the Council on Pharmacy and Chemistry
- EUMICTINE
- Report of the Council on Pharmacy and Chemistry
- PLATT’S CHLORIDES
- Report of the Council on Pharmacy and Chemistry
- ANTI-TUBERCULOUS LYMPH COMPOUND (SWEENY) AND ANTI-SYPHILITIC COMPOUND (SWEENY)
- Report of the Council on Pharmacy and Chemistry
- Anti-Tuberculous Lymph Compound (Sweeny)
- Anti-Syphilitic Compound (Sweeny)
- SYRUP LEPTINOL (FORMERLY SYRUP BALSAMEA)
- Report of the Council on Pharmacy and Chemistry
- FORMITOL TABLETS, II
- Report of the Council on Pharmacy and Chemistry
- SUKRO-SERUM AND APHLEGMATOL
- Report of the Council on Pharmacy and Chemistry
- SUPSALVS NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- HYPODERMIC SOLUTION NO. 13, IRON, ARSENIC AND PHOSPHORUS COMPOUND NOT ACCEPTED FOR N. N. R.
- Report of the Council on Pharmacy and Chemistry
- PARATHESIN NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- CHLORLYPTUS
- Report of the Council on Pharmacy and Chemistry
- I. DETAILED REPORTS
- Summarized Reports
- II. APPENDIX: SPECIAL REPORTS A. COMPARISON OF CHLORLYPTUS WITH CHLORINATED EUCALYPTOL
- From the Chemical Laboratory of the American Medical Association
- B. THE PERSISTENCE OF THE ACID
- Reaction of Chlorlyptus in the Body
- C. TOXICITY EXPERIMENTS
- D. REPORT OF DR. D. RIVAS
- AQUAZONE (OXYGEN WATER)
- Report of the Council on Pharmacy and Chemistry
- COAGULEN-CIBA OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- FERRIC CACODYLATE OMITTED FROM NEW AND NONOFFICIAL REMEDIES
- Report of the Council on Pharmacy and Chemistry
- LIBRADOL
- Report of the Council on Pharmacy and Chemistry
- HELMITOL OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- SPIROCIDE NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- DIGIFOLIN-CIBA NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- SOME OF LOESER’S INTRAVENOUS SOLUTIONS
- Report of the Council on Pharmacy and Chemistry
- “NATIONAL IODINE SOLUTION” NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- MON-ARSONE NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- OXYL-IODIDE NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- QUASSIA COMPOUND TABLETS
- Report of the Council on Pharmacy and Chemistry
- TOXICIDE
- Report of the Council on Pharmacy and Chemistry
- PIL. MIXED TREATMENT (CHICHESTER)
- Report of the Council on Pharmacy and Chemistry
- ATOPHAN OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- UROTROPIN OMITTED FROM N. N. R.
- Report of the Council on Pharmacy and Chemistry
- Commercial History of Hexamethylenamin
- Urotropin Marketed Under Unwarranted Therapeutic Claims
- Urotropin a Brand of Hexamethylenamine, U. S. P.
- STYPTYSATE NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- LIPOIDAL SUBSTANCES (HOROVITZ) NOT ADMITTED TO N. N. R.
- Report of the Council on Pharmacy and Chemistry
- YEAST PREPARATIONS AND VITAMIN B CONCENTRATES
- Report of the Council on Pharmacy and Chemistry
- PART II CONTRIBUTIONS FROM THE A. M. A. CHEMICAL LABORATORY
- FOREWORD
- THE CHEMICAL LABORATORY OF THE AMERICAN MEDICAL ASSOCIATION
- THE WORK OF THE AMERICAN MEDICAL ASSOCIATION CHEMICAL LABORATORY[G]
- LEAD IN “AKOZ”
- Details of Analysis
- SODIUM ACETATE IN WARMING BOTTLES
- ANTI-SYPHILITIC COMPOUND (SWEENY)
- “AMBRINE” AND PARAFFIN FILMS[H]
- Addenda
- THE STABILITY OF IODINE OINTMENTS
- IODOLENE AND THE SOLUBILITY OF IODIN IN LIQUID PETROLATUM
- AMERICAN-MADE SYNTHETIC DRUGS—I
- Examination of American-Made Acetylsalicylic Acid
- THE STANDARDIZATION OF COMMERCIAL BISMUTH TRIBROMPHENATE
- Report to Council of National Defense
- Revision of N. N. R. Standards
- THE STANDARDIZATION OF PROCAIN AND EXAMINATION OF THE MARKET SUPPLY
- DETERIORATION OF SODIUM HYPOCHLORITE SOLUTIONS (“Chlorinated Soda” Solutions)
- SYPHILODOL
- Details of Analysis
- CERELENE
- DR. DE SANCTIS’ RHEUMATIC AND GOUT PILLS
- IODEX AND LIQUID IODEX
- Details of Analysis
- I. G. O.
- IODIN IN LIQUID PETROLATUM
- AMERICAN-MADE SYNTHETIC DRUGS—II
- Examination of Procain (Novocain), Barbital (Veronal), Phenetidyl-Acetphenetidin (Holocain), Cinchophen or Phenylcinchoninic Acid (Atophan), Manufactured Under Federal Trade Commission Licenses[I][J]
- PART III CONTRIBUTIONS FROM THE JOURNAL: PROPRIETARY PRODUCTS
- NOSTRUMS IN RETROSPECT
- A Series of Nine Articles Reviewing Worthless or Unscientific Proprietary Mixtures Previously Criticized
- [Article I]
- Bell-Ans (Pa-Pay-Ans Bell)[K]
- [Article II]
- Anasarcin and Anedemin
- [Article III]
- Pepto-Mangan
- [Article IV]
- Cactina Pillets
- [Article V]
- Ammonol and Phenalgin
- [Article VI]
- Fellows’ Syrup, and Other Preparations of the Hypophosphites
- [Article VII]
- Shotgun Nostrums
- [Article VIII]
- Tyree’s Antiseptic and Aseptinol
- [Article IX]
- ANASARCIN ADVERTISING[L]
- ANTIMERISTEM-SCHMIDT
- ANTIPHLOGISTINE
- “AUTO-HEMIC SERUM”
- A Cure for Laziness, Ugliness, Frigidity and Many Other Things
- “AUTOLYSIN” ADVERTISING
- “BASIC CANCER RESEARCH” AND “COSMOPOLITAN CANCER RESEARCH SOCIETY”
- Seleni-Bascca
- Repudiated by the Brooklyn Bureau of Charities
- BELL-ANS (PAPAYANS, BELL)[M]
- As the New York Tribune’s “Ad-Visor” Sees It
- CAMPHO-PHENIQUE
- Appealing to the New Fledged Graduate.
- “CINCHOPHEN”: FORMERLY “ATOPHAN”
- “COLLOSOLS”: AN UNCRITICAL ENGLISH ENDORSEMENT
- Collosol Manganese
- COTTON PROCESS ETHER
- A Note from the Manufacturers
- DIONOL
- Glorified Petrolatum
- THE ELI PRODUCTS OF ELI H. DUNN
- GLOVER’S CANCER SERUM
- The Toronto Academy of Medicine Reports Unfavorably on Glover’s Cancer Serum
- GLYCO-THYMOLINE AND POLIOMYELITIS
- GLYKERON: COLD STORAGE TESTIMONIALS [N]
- GRAY’S GLYCERINE TONIC: “WHOSE BREAD I EAT HIS SONG I SING”
- HAGEE’S CORDIAL OF COD LIVER OIL
- HYPNO-BROMIC COMPOUND
- INTRAVENOUS COMPOUND (LOFFLER)
- Its Composition and the Peculiar Methods by Which It Is Exploited
- INTRAVENOUS SPECIALTIES
- IODEX
- THE WILLIAM F. KOCH CANCER REMEDY
- Further Comment
- THE LUCAS LABORATORIES’ PRODUCTS
- “PHYLACOGENS” [O]
- PINEOLEUM ADVERTISING METHODS
- Capitalizing the Name and Position of the President of the American Medical Association
- “PROTEAL THERAPY” AND HENRY SMITH WILLIAMS
- PROTEOGENS
- Commercial Therapeutics [P]
- An Alleged Endorsement of Proteogens Repudiated
- The Manufacturer’s Protest and a Reply
- Details of the Alleged Endorsement of Proteogens
- Dr. Broeman’s Final Report on Proteogens
- PULVANE
- SAL HEPATICA
- SALICON
- SO-CALLED SECRETIN PREPARATIONS
- SUCCUS CINERARIA MARITIMA
- Another Illustration of One of the Weaknesses of the Federal Food and Drugs Act
- TEKARKIN
- Edward Percy Robinson’s “Cure” for Cancer
- TYREE’S ANTISEPTIC POWDER AGAIN
- The “Ethical and Commercial Requirements” of the Drug Business
- WHEELER’S TISSUE PHOSPHATES
- BRIEFER PARAGRAPHS
- Alcresta Lotion
- Calcidin Tablets (Abbott)
- Di-Crotalin Treatment of Epilepsy
- Estivin
- Iron Arsenite
- K-Y Lubricating Jelly
- “Nikalgin”
- Pertussin and Syrup of Thyme
- Quinin and Urea Hydrochlorid
- Ricord Pills and House Organ Therapeutics
- Stannoxyl
- Syphilodol
- Thialion
- PART IV CONTRIBUTIONS FROM THE JOURNAL: MISCELLANY
- ALBERT ABRAMS, A.M., M.D., LL.D., F.R.M.S.
- “Spondylotherapy,” “Electronic Reactions,” the “Oscilloclast,” the “Electrobioscope,” Etc.
- Dr. Abrams’ Graduation
- A Defense by Upton Sinclair
- Comment
- ACETYLSALICYLIC ACID, NOT ASPIRIN
- “What’s in a Name?”
- Advertising Principles—Lay and Medical
- “Aspirin”—A Common Name
- “Aspirin Bayer” and the Sterling Products Company
- THE ALLIED MEDICAL ASSOCIATIONS OF AMERICA
- Another Rocket in the Pyrotechnics of Quasimedical Organizations
- “ARSENICALS”
- Pharmacology of Arsenicals
- Salvarsan: Abrogate the Patent
- End the Monopoly
- Arsphenamin
- BEER AND CANCER CURES
- Did the Brewing Interests Advertise Autolysin?
- BIOLOGIC THERAPEUTICS AND ITS COMMERCIAL DOMINATION
- CAPELL’S UROLUETIC TEST
- Another Urinary Test for Syphilis
- CHEMOTHERAPY AND TUMORS [Q][R]
- Richard Weil, M.D., New York
- THE DIRECT SALES COMPANY
- DISCOVERIES AND DISCOVERERS
- “DRUG REFORM”
- As It Appears to the Cleveland Medical Journal
- DRUG THERAPY: THE FALLIBILITY OF TEXTBOOKS
- THOMAS WEBSTER EDGAR
- Tired Rabbits for Diabetes; Ring-Tailed Monkeys for Sex Stimulation
- The Journal Receives a Letter Denouncing “Medical Clerks” and “Biased Sceptres”
- GLYCEROPHOSPHATES
- INFLUENZA VACCINES
- Serums and Vaccines
- INTRAVENOUS THERAPY
- IODIN FUMES
- ITALIAN PHYSICO-CHEMICAL COMPANY
- WHAT IS LIQUID PETROLATUM?
- THE LOWENTHAL POSTGRADUATE COURSE
- Which Tells How to Make Diagnoses Accurately, Scientifically Check the Christian Scientists and Increase Your Earning Power
- MEDICAL SOCIETY OF THE UNITED STATES
- From “Division of Fees” to “Down with Autocracy”
- THE NATIONAL FORMULARY—A REVIEW OF THE FOURTH EDITION
- NONSPECIFIC PROTEIN THERAPY
- WILLARD EALON OGDEN
- A “Specialist in Proctology” and His “Clinics”
- “PATENTS”
- Patent Laws and Patent Office Practice
- Our Archaic Patent Laws
- Patents Perpetuated by Trade Names
- Patenting Therapeutic Agents
- PHARMACEUTICAL BARNUMS
- THE PHARMACOPEIA
- The Ninth Decennial Revision
- Review of Ninth Revision
- PHYSICIAN’S STOCK IN PRESCRIPTION PRODUCTS
- PITUITARY GLAND PREPARATIONS
- PROPRIETORSHIP IN MEDICINE
- The Manufacturer’s Protest
- Why Proprietaries Flourish
- PHILIP RAHTJEN AND HIS DISCOVERIES
- SODIUM CACODYLATE IN SYPHILIS
- TABLETS: DEPENDABILITY OF DOSAGE
- THERAPEUTIC EVIDENCE: ITS CRUCIAL TEST [S][T]
- Torald Sollmann, M.D., Cleveland
- “VACCINES IN TOXIC CONDITIONS”
- Commercialized Propaganda in the Guise of Science
- VITAMINS: THEIR DISTRIBUTION
- Our Knowledge of Vitamins
- The Demand for Vitamins
- THE WILLIAM A. WEBSTER CO. AND THE DIRECT PHARMACEUTICAL CO.
- YEAST
- Yeast and Its Uses
- BRIEFER PARAGRAPHS
- Laxol and Lysol—The Short and Catchy Proprietary Name
- Look Up Its Rating
- The Medical Profession and Commercial Interests
- Rabbit-Foot Therapy
- Secret Remedies and the Principles of Ethics
- “Sterling Violet Ray Generator”
- Strontium Salicylate Not Superior to Sodium Salicylate
- Vaccine As a Prophylactic in Influenza
- Vaccines for “Colds”
- INDEX AND BIBLIOGRAPHY
- FOOTNOTES:
- iv
- vi
- x
- xi
- xii
- xiii
- xiv
- 1
- 3
- 5
- 6
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 25
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 35
- 36
- 37
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 71
- 72
- 73
- 75
- 76
- 77
- 78
- 79
- 80
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 126
- 127
- 128
- 129
- 131
- 132
- 133
- 134
- 135
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 148
- 149
- 150
- 151
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 166
- 167
- 168
- 169
- 170
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- 227
- 228
- 229
- 230
- 231
- 232
- 233
- 234
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- 248
- 249
- 250
- 251
- 252
- 253
- 254
- 255
- 256
- 258
- 259
- 260
- 261
- 262
- 263
- 264
- 265
- 266
- 267
- 268
- 269
- 270
- 271
- 272
- 273
- 274
- 275
- 276
- 277
- 278
- 279
- 280
- 281
- 282
- 283
- 284
- 285
- 286
- 287
- 288
- 289
- 290
- 291
- 292
- 293
- 294
- 296
- 297
- 298
- 299
- 300
- 301
- 302
- 304
- 305
- 306
- 307
- 308
- 309
- 310
- 311
- 312
- 313
- 314
- 315
- 316
- 317
- 318
- 319
- 320
- 321
- 322
- 323
- 324
- 326
- 328
- 331
- 333
- 334
- 335
- 337
- 338
- 339
- 340
- 341
- 342
- 343
- 344
- 345
- 347
- 348
- 349
- 350
- 351
- 352
- 353
- 354
- 355
- 356
- 357
- 358
- 359
- 360
- 361
- 362
- 363
- 364
- 365
- 366
- 367
- 368
- 369
- 370
- 371
- 372
- 373
- 374
- 375
- 376
- 377
- 378
- 379
- 380
- 381
- 382
- 383
- 384
- 385
- 386
- 387
- 388
- 389
- 390
- 391
- 392
- 393
- 394
- 395
- 396
- 397
- 398
- 399
- 400
- 401
- 402
- 403
- 404
- 405
- 406
- 407
- 408
- 410
- 411
- 412
- 413
- 414
- 415
- 416
- 418
- 419
- 420
- 422
- 423
- 424
- 426
- 427
- 428
- 429
- 430
- 431
- 432
- 433
- 434
- 435
- 436
- 437
- 438
- 439
- 440
- 441
- 442
- 443
- 444
- 445
- 446
- 447
- 449
- 450
- 451
- 452
- 453
- 454
- 456
- 457
- 458
- 459
- 460
- 461
- 462
- 463
- 465
- 467
- 468
- 469
- 470
- 471
- 472
- 473
- 474
- 475
- 476
- 477
- 478
- 479
- 480
- 482
- 484
- 485
- 486
- 487
- 488
- 490
- 492
- 493
- 494
- 495
- 496
- 497
- 498
- 499
- 500
- 501
- 503
- 505
- 506
- 509
- 511
- 512
- 513
- 514
- 515
- 516
- 517
- 518
- 519
- 520
- 523
- 524
- 525
- 527
- 528
- 529
- 530
- 531
- 532
- 533
- 534
- 535
- 536
- 537
- 538
- 539
- 540
- 541
- 543
- 544
- 545
- 546
- 550
- 551
- 553
- 554
- 555
- 557
- 558
- 559
- 560
- 561
- 562
- 563
- 564
- 565
- 566
- 567
- 568
- 569
- 570
- 572
- 575
- 576
- 577
- 578
- 579
- 580
- 581
- 582
- 583
- 584
- 585
- 586
- 587
- 588
- 589
- 590
- 591
- 592
- 593
- 594
- 595
- 596
- 597
- 598
- 599
- 600
- 601
- 602
- 603
How to Listen
- 1. Click "Listen Free" above
- 2. The book opens in CastReader's browser reader
- 3. Click the play button — AI narration starts with word highlighting
- 4. Use "Send to Phone" to continue listening on your phone
FAQ
Is this audiobook really free?
Yes. "The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2" is a public domain work from Project Gutenberg. CastReader converts it to audio using AI text-to-speech for free. No account or payment needed.
What does the AI voice sound like?
CastReader uses Kokoro TTS, a natural-sounding AI voice. It handles punctuation, names, and dialogue naturally. Most listeners forget it's AI after a few minutes.
Can I listen on my phone?
Yes. Open the book, then use "Send to Phone" to stream audio to your phone via Telegram. No app download needed.